Papillary carcinoma
MONDO:0006509A malignant epithelial neoplasm characterized by a papillary growth pattern. A papillary carcinoma may be composed of glandular cells (papillary adenocarcinoma), squamous cells (papillary squamous cell carcinoma), or transitional cells (papillary transitional cell carcinoma). Bladder carcinoma is a representative example of papillary transitional cell carcinoma.
Also known as: papillary carcinoma, papillary carcinoma (morphologic abnormality), papillary carcinoma NOS (morphologic abnormality)
2844 clinical trials for this condition and its sub-types, 8 tagged with Papillary carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Papillary carcinoma
-
Papillary adenocarcinoma 2 trials · 92 incl. sub-types
11 sub-types
- Thyroid gland papillary carcinoma 59 trials · 60 incl. sub-types Sub-types →
- Papillary renal cell carcinoma 25 trials · 27 incl. sub-types Sub-types →
- Ovarian serous surface papillary adenocarcinoma 2 trials
- Breast papillary carcinoma 1 trial Sub-types →
- Papillary eccrine carcinoma 1 trial Sub-types →
- Fallopian tube papillary adenocarcinoma 0 trials
- Gallbladder papillary neoplasm with an associated invasive carcinoma 0 trials
- Gastric papillary adenocarcinoma 0 trials
- Papillary cystadenocarcinoma 0 trials Sub-types →
- Papillary lung adenocarcinoma 0 trials
- Papillary thymic adenocarcinoma 0 trials
-
Papillary transitional cell carcinoma 1 trial · 11 incl. sub-types
2 sub-types
-
Papillary squamous carcinoma 1 trial · 4 incl. sub-types
2 sub-types
- Verrucous carcinoma 0 trials · 3 incl. sub-types Sub-types →
- Papillary carcinoma of the penis 0 trials Sub-types →
-
1 sub-type
- Cervical verrucous carcinoma 0 trials
Most studied deeper sub-types
-
Could Once-Daily radiation replace Twice-Daily for breast cancer recurrence?
Disease control Recruiting nowThis study is for women whose breast cancer has come back after initial breast-conserving surgery and whole breast radiation. The standard treatment after repeat surgery is radiation twice a day for 30 sessions. This trial tests whether giving radiation once a day for 15 sessions…
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New Alpha-Particle drug targets Hard-to-Treat thyroid cancer
Disease control Recruiting nowThis early-stage trial tests a new radioactive drug called Af-001 in people with advanced differentiated thyroid cancer that cannot be removed by surgery or has spread. The study has two parts: first, to find the safest dose, and second, to see if multiple doses can shrink tumors…
Phase 1 • Sponsor: Alpha Fusion Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC